The global Sacubitril Valsartan Sodium Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Sacubitril/valsartan sodium drugs refer to medications that combine two active ingredients, sacubitril and valsartan, used primarily for treating heart failure.

From a downstream perspective, Hospital and Clinic accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Sacubitril Valsartan Sodium Drugs leading manufacturers including Novartis, MSN, Arlak Corazon, Sanof, Cipla, Farmanova pharma, General Pharmaceuticals, Addii Biotech, Qilu Pharmaceutical, Chengdu Brilliant Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Novartis leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Sacubitril Valsartan Sodium Drugs market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Sacubitril Valsartan Sodium Drugs Market Report

Report Metric	Details
Report Name	Sacubitril Valsartan Sodium Drugs Market
Segment by Type	Tablets Oral Pellets
Segment by Application	Hospital and Clinic Retail Pharmacies Other
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, MSN, Arlak Corazon, Sanof, Cipla, Farmanova pharma, General Pharmaceuticals, Addii Biotech, Qilu Pharmaceutical, Chengdu Brilliant Pharmaceutical, TC Pharmaceuticals (Jiangsu), Chia Tai Tianqing Pharmaceutical, CSPC Ouyi Pharmaceutical, Changzhou Pharmaceutical Factory, Zhejiang Nord Pharmaceutical, Kelun Pharmaceutical, Sihuan Pharmaceutical, Sino Therapeutics, Zhejiang AngLiKang Pharmaceutical, Shenzhen Salubris Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Sacubitril Valsartan Sodium Drugs study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Sacubitril Valsartan Sodium Drugs Market report?

Ans: The main players in the Sacubitril Valsartan Sodium Drugs Market are Novartis, MSN, Arlak Corazon, Sanof, Cipla, Farmanova pharma, General Pharmaceuticals, Addii Biotech, Qilu Pharmaceutical, Chengdu Brilliant Pharmaceutical, TC Pharmaceuticals (Jiangsu), Chia Tai Tianqing Pharmaceutical, CSPC Ouyi Pharmaceutical, Changzhou Pharmaceutical Factory, Zhejiang Nord Pharmaceutical, Kelun Pharmaceutical, Sihuan Pharmaceutical, Sino Therapeutics, Zhejiang AngLiKang Pharmaceutical, Shenzhen Salubris Pharmaceuticals

What are the Application segmentation covered in the Sacubitril Valsartan Sodium Drugs Market report?

Ans: The Applications covered in the Sacubitril Valsartan Sodium Drugs Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Sacubitril Valsartan Sodium Drugs Market report?

Ans: The Types covered in the Sacubitril Valsartan Sodium Drugs Market report are Tablets, Oral Pellets

1 Study Coverage

1.1 Introduction to Sacubitril Valsartan Sodium Drugs: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Sacubitril Valsartan Sodium Drugs Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Tablets

1.2.3 Oral Pellets

1.3 Market Segmentation by Application

1.3.1 Global Sacubitril Valsartan Sodium Drugs Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital and Clinic

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Sacubitril Valsartan Sodium Drugs Revenue Estimates and Forecasts 2020-2031

2.2 Global Sacubitril Valsartan Sodium Drugs Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Sacubitril Valsartan Sodium Drugs Sales Estimates and Forecasts 2020-2031

2.4 Global Sacubitril Valsartan Sodium Drugs Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Sacubitril Valsartan Sodium Drugs Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Sacubitril Valsartan Sodium Drugs Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Tablets Market Size by Manufacturers

3.5.2 Oral Pellets Market Size by Manufacturers

3.6 Global Sacubitril Valsartan Sodium Drugs Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Sacubitril Valsartan Sodium Drugs Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Sacubitril Valsartan Sodium Drugs Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Sacubitril Valsartan Sodium Drugs Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Sacubitril Valsartan Sodium Drugs Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)

6.4 North America Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Sacubitril Valsartan Sodium Drugs Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)

7.4 Europe Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Sacubitril Valsartan Sodium Drugs Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)

9.4 Central and South America Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Sacubitril Valsartan Sodium Drugs Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Novartis

11.1.1 Novartis Corporation Information

11.1.2 Novartis Business Overview

11.1.3 Novartis Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.1.4 Novartis Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Novartis Sacubitril Valsartan Sodium Drugs Sales by Product in 2024

11.1.6 Novartis Sacubitril Valsartan Sodium Drugs Sales by Application in 2024

11.1.7 Novartis Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024

11.1.8 Novartis Sacubitril Valsartan Sodium Drugs SWOT Analysis

11.1.9 Novartis Recent Developments

11.2 MSN

11.2.1 MSN Corporation Information

11.2.2 MSN Business Overview

11.2.3 MSN Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.2.4 MSN Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 MSN Sacubitril Valsartan Sodium Drugs Sales by Product in 2024

11.2.6 MSN Sacubitril Valsartan Sodium Drugs Sales by Application in 2024

11.2.7 MSN Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024

11.2.8 MSN Sacubitril Valsartan Sodium Drugs SWOT Analysis

11.2.9 MSN Recent Developments

11.3 Arlak Corazon

11.3.1 Arlak Corazon Corporation Information

11.3.2 Arlak Corazon Business Overview

11.3.3 Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.3.4 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales by Product in 2024

11.3.6 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales by Application in 2024

11.3.7 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024

11.3.8 Arlak Corazon Sacubitril Valsartan Sodium Drugs SWOT Analysis

11.3.9 Arlak Corazon Recent Developments

11.4 Sanof

11.4.1 Sanof Corporation Information

11.4.2 Sanof Business Overview

11.4.3 Sanof Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.4.4 Sanof Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Sanof Sacubitril Valsartan Sodium Drugs Sales by Product in 2024

11.4.6 Sanof Sacubitril Valsartan Sodium Drugs Sales by Application in 2024

11.4.7 Sanof Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024

11.4.8 Sanof Sacubitril Valsartan Sodium Drugs SWOT Analysis

11.4.9 Sanof Recent Developments

11.5 Cipla

11.5.1 Cipla Corporation Information

11.5.2 Cipla Business Overview

11.5.3 Cipla Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.5.4 Cipla Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Cipla Sacubitril Valsartan Sodium Drugs Sales by Product in 2024

11.5.6 Cipla Sacubitril Valsartan Sodium Drugs Sales by Application in 2024

11.5.7 Cipla Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024

11.5.8 Cipla Sacubitril Valsartan Sodium Drugs SWOT Analysis

11.5.9 Cipla Recent Developments

11.6 Farmanova pharma

11.6.1 Farmanova pharma Corporation Information

11.6.2 Farmanova pharma Business Overview

11.6.3 Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.6.4 Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Farmanova pharma Recent Developments

11.7 General Pharmaceuticals

11.7.1 General Pharmaceuticals Corporation Information

11.7.2 General Pharmaceuticals Business Overview

11.7.3 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.7.4 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 General Pharmaceuticals Recent Developments

11.8 Addii Biotech

11.8.1 Addii Biotech Corporation Information

11.8.2 Addii Biotech Business Overview

11.8.3 Addii Biotech Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.8.4 Addii Biotech Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Addii Biotech Recent Developments

11.9 Qilu Pharmaceutical

11.9.1 Qilu Pharmaceutical Corporation Information

11.9.2 Qilu Pharmaceutical Business Overview

11.9.3 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.9.4 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Qilu Pharmaceutical Recent Developments

11.10 Chengdu Brilliant Pharmaceutical

11.10.1 Chengdu Brilliant Pharmaceutical Corporation Information

11.10.2 Chengdu Brilliant Pharmaceutical Business Overview

11.10.3 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.10.4 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Chengdu Brilliant Pharmaceutical Recent Developments

11.11 TC Pharmaceuticals (Jiangsu)

11.11.1 TC Pharmaceuticals (Jiangsu) Corporation Information

11.11.2 TC Pharmaceuticals (Jiangsu) Business Overview

11.11.3 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.11.4 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 TC Pharmaceuticals (Jiangsu) Recent Developments

11.12 Chia Tai Tianqing Pharmaceutical

11.12.1 Chia Tai Tianqing Pharmaceutical Corporation Information

11.12.2 Chia Tai Tianqing Pharmaceutical Business Overview

11.12.3 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.12.4 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments

11.13 CSPC Ouyi Pharmaceutical

11.13.1 CSPC Ouyi Pharmaceutical Corporation Information

11.13.2 CSPC Ouyi Pharmaceutical Business Overview

11.13.3 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.13.4 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 CSPC Ouyi Pharmaceutical Recent Developments

11.14 Changzhou Pharmaceutical Factory

11.14.1 Changzhou Pharmaceutical Factory Corporation Information

11.14.2 Changzhou Pharmaceutical Factory Business Overview

11.14.3 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.14.4 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 Changzhou Pharmaceutical Factory Recent Developments

11.15 Zhejiang Nord Pharmaceutical

11.15.1 Zhejiang Nord Pharmaceutical Corporation Information

11.15.2 Zhejiang Nord Pharmaceutical Business Overview

11.15.3 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.15.4 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Zhejiang Nord Pharmaceutical Recent Developments

11.16 Kelun Pharmaceutical

11.16.1 Kelun Pharmaceutical Corporation Information

11.16.2 Kelun Pharmaceutical Business Overview

11.16.3 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.16.4 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.16.5 Kelun Pharmaceutical Recent Developments

11.17 Sihuan Pharmaceutical

11.17.1 Sihuan Pharmaceutical Corporation Information

11.17.2 Sihuan Pharmaceutical Business Overview

11.17.3 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.17.4 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.17.5 Sihuan Pharmaceutical Recent Developments

11.18 Sino Therapeutics

11.18.1 Sino Therapeutics Corporation Information

11.18.2 Sino Therapeutics Business Overview

11.18.3 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.18.4 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.18.5 Sino Therapeutics Recent Developments

11.19 Zhejiang AngLiKang Pharmaceutical

11.19.1 Zhejiang AngLiKang Pharmaceutical Corporation Information

11.19.2 Zhejiang AngLiKang Pharmaceutical Business Overview

11.19.3 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.19.4 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.19.5 Zhejiang AngLiKang Pharmaceutical Recent Developments

11.20 Shenzhen Salubris Pharmaceuticals

11.20.1 Shenzhen Salubris Pharmaceuticals Corporation Information

11.20.2 Shenzhen Salubris Pharmaceuticals Business Overview

11.20.3 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications

11.20.4 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)

11.20.5 Shenzhen Salubris Pharmaceuticals Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Sacubitril Valsartan Sodium Drugs Industry Chain

12.2 Sacubitril Valsartan Sodium Drugs Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Sacubitril Valsartan Sodium Drugs Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Sacubitril Valsartan Sodium Drugs Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Sacubitril Valsartan Sodium Drugs Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Sacubitril Valsartan Sodium Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

General Pharmaceuticals

Addii Biotech

Qilu Pharmaceutical

Chengdu Brilliant Pharmaceutical

TC Pharmaceuticals (Jiangsu)

Chia Tai-Tianqing Pharmaceutical

CSPC Ouyi Pharmaceutical

Changzhou Pharmaceutical Factory

Zhejiang Nord Pharmaceutical

Kelun Pharmaceutical

Sihuan Pharmaceutical

Sino Therapeutics

Zhejiang Anglikang Pharmaceutical

Shenzhen Salubris Pharmaceuticals

List of Tables

Table 1. Global Sacubitril Valsartan Sodium Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Sacubitril Valsartan Sodium Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Sacubitril Valsartan Sodium Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Sacubitril Valsartan Sodium Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Sacubitril Valsartan Sodium Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2020-2025) & (K Units)

Table 8. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Sacubitril Valsartan Sodium Drugs Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Sacubitril Valsartan Sodium Drugs Sales Share by Manufacturers (2020-2025)

Table 12. Global Sacubitril Valsartan Sodium Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Sacubitril Valsartan Sodium Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacubitril Valsartan Sodium Drugs as of 2024)

Table 16. Global Sacubitril Valsartan Sodium Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Sacubitril Valsartan Sodium Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Sacubitril Valsartan Sodium Drugs Manufacturing Base and Headquarters

Table 19. Global Sacubitril Valsartan Sodium Drugs Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2020-2025) & (K Units)

Table 23. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2026-2031) & (K Units)

Table 24. Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Sacubitril Valsartan Sodium Drugs ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2020-2025) & (K Units)

Table 29. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2026-2031) & (K Units)

Table 30. Sacubitril Valsartan Sodium Drugs High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Sacubitril Valsartan Sodium Drugs ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Sacubitril Valsartan Sodium Drugs Growth Accelerators and Market Barriers

Table 37. North America Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Sacubitril Valsartan Sodium Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Sacubitril Valsartan Sodium Drugs Growth Accelerators and Market Barriers

Table 40. Europe Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Sacubitril Valsartan Sodium Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Sacubitril Valsartan Sodium Drugs Growth Accelerators and Market Barriers

Table 45. Southeast Asia Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Sacubitril Valsartan Sodium Drugs Investment Opportunities and Key Challenges

Table 47. Central and South America Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Sacubitril Valsartan Sodium Drugs Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Novartis Corporation Information

Table 51. Novartis Description and Major Businesses

Table 52. Novartis Product Models, Descriptions and Specifications

Table 53. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Novartis Sales Value Proportion by Product in 2024

Table 55. Novartis Sales Value Proportion by Application in 2024

Table 56. Novartis Sales Value Proportion by Geographic Area in 2024

Table 57. Novartis Sacubitril Valsartan Sodium Drugs SWOT Analysis

Table 58. Novartis Recent Developments

Table 59. MSN Corporation Information

Table 60. MSN Description and Major Businesses

Table 61. MSN Product Models, Descriptions and Specifications

Table 62. MSN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. MSN Sales Value Proportion by Product in 2024

Table 64. MSN Sales Value Proportion by Application in 2024

Table 65. MSN Sales Value Proportion by Geographic Area in 2024

Table 66. MSN Sacubitril Valsartan Sodium Drugs SWOT Analysis

Table 67. MSN Recent Developments

Table 68. Arlak Corazon Corporation Information

Table 69. Arlak Corazon Description and Major Businesses

Table 70. Arlak Corazon Product Models, Descriptions and Specifications

Table 71. Arlak Corazon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Arlak Corazon Sales Value Proportion by Product in 2024

Table 73. Arlak Corazon Sales Value Proportion by Application in 2024

Table 74. Arlak Corazon Sales Value Proportion by Geographic Area in 2024

Table 75. Arlak Corazon Sacubitril Valsartan Sodium Drugs SWOT Analysis

Table 76. Arlak Corazon Recent Developments

Table 77. Sanof Corporation Information

Table 78. Sanof Description and Major Businesses

Table 79. Sanof Product Models, Descriptions and Specifications

Table 80. Sanof Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Sanof Sales Value Proportion by Product in 2024

Table 82. Sanof Sales Value Proportion by Application in 2024

Table 83. Sanof Sales Value Proportion by Geographic Area in 2024

Table 84. Sanof Sacubitril Valsartan Sodium Drugs SWOT Analysis

Table 85. Sanof Recent Developments

Table 86. Cipla Corporation Information

Table 87. Cipla Description and Major Businesses

Table 88. Cipla Product Models, Descriptions and Specifications

Table 89. Cipla Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Cipla Sales Value Proportion by Product in 2024

Table 91. Cipla Sales Value Proportion by Application in 2024

Table 92. Cipla Sales Value Proportion by Geographic Area in 2024

Table 93. Cipla Sacubitril Valsartan Sodium Drugs SWOT Analysis

Table 94. Cipla Recent Developments

Table 95. Farmanova pharma Corporation Information

Table 96. Farmanova pharma Description and Major Businesses

Table 97. Farmanova pharma Product Models, Descriptions and Specifications

Table 98. Farmanova pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Farmanova pharma Recent Developments

Table 100. General Pharmaceuticals Corporation Information

Table 101. General Pharmaceuticals Description and Major Businesses

Table 102. General Pharmaceuticals Product Models, Descriptions and Specifications

Table 103. General Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. General Pharmaceuticals Recent Developments

Table 105. Addii Biotech Corporation Information

Table 106. Addii Biotech Description and Major Businesses

Table 107. Addii Biotech Product Models, Descriptions and Specifications

Table 108. Addii Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Addii Biotech Recent Developments

Table 110. Qilu Pharmaceutical Corporation Information

Table 111. Qilu Pharmaceutical Description and Major Businesses

Table 112. Qilu Pharmaceutical Product Models, Descriptions and Specifications

Table 113. Qilu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Qilu Pharmaceutical Recent Developments

Table 115. Chengdu Brilliant Pharmaceutical Corporation Information

Table 116. Chengdu Brilliant Pharmaceutical Description and Major Businesses

Table 117. Chengdu Brilliant Pharmaceutical Product Models, Descriptions and Specifications

Table 118. Chengdu Brilliant Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Chengdu Brilliant Pharmaceutical Recent Developments

Table 120. TC Pharmaceuticals (Jiangsu) Corporation Information

Table 121. TC Pharmaceuticals (Jiangsu) Description and Major Businesses

Table 122. TC Pharmaceuticals (Jiangsu) Product Models, Descriptions and Specifications

Table 123. TC Pharmaceuticals (Jiangsu) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. TC Pharmaceuticals (Jiangsu) Recent Developments

Table 125. Chia Tai Tianqing Pharmaceutical Corporation Information

Table 126. Chia Tai Tianqing Pharmaceutical Description and Major Businesses

Table 127. Chia Tai Tianqing Pharmaceutical Product Models, Descriptions and Specifications

Table 128. Chia Tai Tianqing Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Chia Tai Tianqing Pharmaceutical Recent Developments

Table 130. CSPC Ouyi Pharmaceutical Corporation Information

Table 131. CSPC Ouyi Pharmaceutical Description and Major Businesses

Table 132. CSPC Ouyi Pharmaceutical Product Models, Descriptions and Specifications

Table 133. CSPC Ouyi Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. CSPC Ouyi Pharmaceutical Recent Developments

Table 135. Changzhou Pharmaceutical Factory Corporation Information

Table 136. Changzhou Pharmaceutical Factory Description and Major Businesses

Table 137. Changzhou Pharmaceutical Factory Product Models, Descriptions and Specifications

Table 138. Changzhou Pharmaceutical Factory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. Changzhou Pharmaceutical Factory Recent Developments

Table 140. Zhejiang Nord Pharmaceutical Corporation Information

Table 141. Zhejiang Nord Pharmaceutical Description and Major Businesses

Table 142. Zhejiang Nord Pharmaceutical Product Models, Descriptions and Specifications

Table 143. Zhejiang Nord Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. Zhejiang Nord Pharmaceutical Recent Developments

Table 145. Kelun Pharmaceutical Corporation Information

Table 146. Kelun Pharmaceutical Description and Major Businesses

Table 147. Kelun Pharmaceutical Product Models, Descriptions and Specifications

Table 148. Kelun Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 149. Kelun Pharmaceutical Recent Developments

Table 150. Sihuan Pharmaceutical Corporation Information

Table 151. Sihuan Pharmaceutical Description and Major Businesses

Table 152. Sihuan Pharmaceutical Product Models, Descriptions and Specifications

Table 153. Sihuan Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 154. Sihuan Pharmaceutical Recent Developments

Table 155. Sino Therapeutics Corporation Information

Table 156. Sino Therapeutics Description and Major Businesses

Table 157. Sino Therapeutics Product Models, Descriptions and Specifications

Table 158. Sino Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 159. Sino Therapeutics Recent Developments

Table 160. Zhejiang AngLiKang Pharmaceutical Corporation Information

Table 161. Zhejiang AngLiKang Pharmaceutical Description and Major Businesses

Table 162. Zhejiang AngLiKang Pharmaceutical Product Models, Descriptions and Specifications

Table 163. Zhejiang AngLiKang Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 164. Zhejiang AngLiKang Pharmaceutical Recent Developments

Table 165. Shenzhen Salubris Pharmaceuticals Corporation Information

Table 166. Shenzhen Salubris Pharmaceuticals Description and Major Businesses

Table 167. Shenzhen Salubris Pharmaceuticals Product Models, Descriptions and Specifications

Table 168. Shenzhen Salubris Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 169. Shenzhen Salubris Pharmaceuticals Recent Developments

Table 170. Key Raw Materials Distribution

Table 171. Raw Materials Key Suppliers

Table 172. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 173. Milestones in Production Technology Evolution

Table 174. Distributors List

Table 175. Market Trends and Market Evolution

Table 176. Market Drivers and Opportunities

Table 177. Market Challenges, Risks, and Restraints

Table 178. Research Programs/Design for This Report

Table 179. Key Data Information from Secondary Sources

Table 180. Key Data Information from Primary Sources

List of Figures

Figure 1. Sacubitril Valsartan Sodium Drugs Product Picture

Figure 2. Global Sacubitril Valsartan Sodium Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Tablets Product Picture

Figure 4. Oral Pellets Product Picture

Figure 5. Global Sacubitril Valsartan Sodium Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital and Clinic

Figure 7. Retail Pharmacies

Figure 8. Other

Figure 9. Sacubitril Valsartan Sodium Drugs Report Years Considered

Figure 10. Global Sacubitril Valsartan Sodium Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 12. Global Sacubitril Valsartan Sodium Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Region (2020-2031)

Figure 14. Global Sacubitril Valsartan Sodium Drugs Sales (2020-2031) & (K Units)

Figure 15. Global Sacubitril Valsartan Sodium Drugs Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Volume Market Share in 2024

Figure 18. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Tablets Revenue Market Share by Manufacturer in 2024

Figure 21. Oral Pellets Revenue Market Share by Manufacturer in 2024

Figure 22. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Type (2020-2031)

Figure 23. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Type (2020-2031)

Figure 24. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Application (2020-2031)

Figure 25. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Application (2020-2031)

Figure 26. North America Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)

Figure 27. North America Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024

Figure 29. North America Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2020- 2031)

Figure 30. North America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 32. North America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)

Figure 37. Europe Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024

Figure 39. Europe Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2020-2031)

Figure 40. Europe Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 42. Europe Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 44. France Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)

Figure 49. Asia-Pacific Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2020- 2031)

Figure 52. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 54. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 59. India Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)

Figure 61. Central and South America Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2021-2031)

Figure 64. Central and South America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 66. Central and South America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)

Figure 70. Middle East and Africa Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2021-2031)

Figure 73. South America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)

Figure 75. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)

Figure 80. Sacubitril Valsartan Sodium Drugs Industry Chain Mapping

Figure 81. Regional Sacubitril Valsartan Sodium Drugs Manufacturing Base Distribution (%)

Figure 82. Global Sacubitril Valsartan Sodium Drugs Production Market Share by Region (2020-2031)

Figure 83. Sacubitril Valsartan Sodium Drugs Production Process

Figure 84. Regional Sacubitril Valsartan Sodium Drugs Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions